Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $122.40 | Total: $612.00 |
| 1 | 10 | $103.68 | Total: $1,036.80 |
| 1 | 25 | $87.84 | Total: $2,196.00 |
| 1 | 50 | $74.88 | Total: $3,744.00 |
| 1 | 100 | $64.80 | Total: $6,480.00 |
Overview
Quilseconazole Formic acid is a selective inhibitor of fungal Cyp51 with potent activities against Cryptococcus neoformans and Cryptococcus gattii.
Chemical Properties
| Molecular Formula | C23H16F7N5O4 |
| Molecular Weight | 559.39 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | FC(F)(C1=CC=C(C2=CC=C(C=C2)OC(F)(F)F)C=N1)[C@@](O)(C3=C(C=C(C=C3)F)F)CN4C=NN=N4.O=C(O)[H] |
Storage and Handling
0C Short Term, -20C Long Term
References
Lockhart SR, et al. The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii. Antimicrob Agents Chemother. 2016 Mar 25;60[4] 2528-31.